Upgrade to SI Premium - Free Trial

Oppenheimer Cuts Price Target as Gilead Sciences (GILD) Reports 1Q Miss

May 4, 2016 8:43 AM
Oppenheimer maintained an Outperform rating on Gilead Sciences (NASDAQ: GILD), and cut the price target to $116.00 (from $120.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles